Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Añadir filtros








Intervalo de año
1.
Braz. j. med. biol. res ; 53(3): e9201, 2020. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1089347

RESUMEN

Methylophiopogonanone A (MO-A), a homoisoflavonoid extracted from Ophiopogon japonicus, has been shown to attenuate myocardial apoptosis and improve cerebral ischemia/reperfusion injury. However, the hypolipidemic effects remain unknown. This study was performed to investigate a potential hypolipidemic effect of MO-A in hyperlipidemia rats, as well as its underlying mechanism of action. A rat model of hyperlipidemia was induced by a high-fat diet (HFD). Animals were randomly divided into three groups (n=8/group): normal control group (NC), HFD group, and HFD+MO-A (10 mg·kg-1·d-1) treatment group. The effects of MO-A on serum lipids, body weight, activity of lipoprotein metabolism enzyme, and gene expression of lipid metabolism were evaluated in HFD-induced rats. In HFD-induced rats, pretreatment with MO-A decreased the body weight gain and reduced serum and hepatic lipid levels. In addition, pretreatment with MO-A improved the activities of lipoprotein lipase and hepatic lipase in serum and liver, down-regulated mRNA expression of acetyl CoA carboxylase and sterol regulatory element-binding protein 1c, and up-regulated mRNA expression of low-density lipoprotein receptor and peroxisome proliferator-activated receptor α in the liver. Our results indicated that MO-A showed strong ability to ameliorate the hyperlipidemia in HFD-induced rats. MO-A might be a potential candidate for prevention of overweight and dyslipidemia induced by HFD.


Asunto(s)
Animales , Masculino , Ratas , Ophiopogon/química , Benzodioxoles/farmacología , Metabolismo de los Lípidos , Dieta Alta en Grasa , Hiperlipidemias/prevención & control , Isoflavonas/farmacología , Western Blotting , Ratas Sprague-Dawley , Modelos Animales de Enfermedad , Benzodioxoles/aislamiento & purificación , Heces/química , Reacción en Cadena en Tiempo Real de la Polimerasa , Hiperlipidemias/metabolismo , Isoflavonas/aislamiento & purificación , Lípidos/análisis
2.
Braz. j. microbiol ; 47(1): 159-166, Jan.-Mar. 2016. tab, graf
Artículo en Inglés | LILACS | ID: lil-775100

RESUMEN

Abstract A bioassay-guided fractionation of two samples of Brazilian red propolis (from Igarassu, PE, Brazil, hereinafter propolis 1 and 2) was conducted in order to determine the components responsible for its antimicrobial activity, especially against Candida spp. Samples of both the crude powdered resin and the crude ethanolic extract of propolis from both locations inhibited the growth of all 12 tested Candida strains, with a minimum inhibitory concentration of 256 µg/mL. The hexane, acetate and methanol fractions of propolis 1 also inhibited all strains with minimum inhibitory concentration values ranging from 128 to 512 µg/mL for the six bacteria tested and from 32 to 1024 µg/mL for the yeasts. Similarly, hexane and acetate fractions of propolis sample 2 inhibited all microorganisms tested, with minimum inhibitory concentration values of 512 µg/mL for bacteria and 32 µg/mL for yeasts. The extracts were analyzed by HPLC and their phenolic profile allowed us to identify and quantitate one phenolic acid and seven flavonoids in the crude ethanolic extract. Formononetin and pinocembrin were the major constituents amongst the identified compounds. Formononetin was detected in all extracts and fractions tested, except for the methanolic fraction of sample 2. The isolated isoflavone formononetin inhibited the growth of all the microorganisms tested, with a minimum inhibitory concentration of 200 µg/mL for the six bacteria strains tested and 25 µg/mL for the six yeasts. Formononetin also exhibited fungicidal activity against five of the six yeasts tested. Taken together our results demonstrate that the isoflavone formononetin is implicated in the reported antimicrobial activity of red propolis.


Asunto(s)
Antiinfecciosos/farmacología , Candida/efectos de los fármacos , Isoflavonas/aislamiento & purificación , Isoflavonas/farmacología , Própolis/química , Antiinfecciosos/aislamiento & purificación , Brasil , Bacterias/efectos de los fármacos , Fraccionamiento Químico , Cromatografía Líquida de Alta Presión , Pruebas de Sensibilidad Microbiana
3.
Braz. j. med. biol. res ; 42(6): 545-550, June 2009. graf, tab
Artículo en Inglés | LILACS | ID: lil-512768

RESUMEN

Since the anti-inflammatory, antidiabetic and hypolipidemic effects of soy isoflavones may be mediated by activation of peroxisome proliferator-activated receptors (PPAR), the present study investigated whether the methanolic fractions obtained from soybean seeds (E1) and soybean seed coats with hypocotyls (E2) could influence PPARα, PPARγ and PPARβ/δ transcriptional activity. The isoflavones from E1 and E2 were quantified by HPLC analysis. E1 and E2 were rich in isoflavones (daidzin, glycitin, genistin, malonyldaidzin, malonylglycitin, malonylgenistin, daidzein, glycitein, and genistein). Moreover, E1 and E2 showed no evidence of genetically modified material containing the gene CP4 EPSPS. To investigate PPAR transcriptional activity, human promonocytic U-937 cells were treated with E1 and E2 (200, 400, 800, and 1600 µg/mL), positive controls or vehicle. Data are reported as fold-activation of the luciferase reporter driven by the PPAR-responsive element. Dose-response analysis revealed that E1 and E2 induced the transcriptional activity of PPARα (P < 0.001), with activation comparable to that obtained with 0.1 mM bezafibrate (positive control) at 1600 µg/mL (4-fold) and 800 µg/mL (9-fold), respectively. In addition, dose-response analysis revealed that E1 and E2 activated PPARβ/δ (P < 0.05), and the activation at 800 µg/mL (4- and 9-fold, respectively) was comparable to that of 0.1 mM bezafibrate (positive control). However, no effect on PPARγ was observed. Activation of PPARα is consistent with the lipid-lowering activity of soy isoflavones in vivo, but further studies are needed to determine the physiological significance of PPARβ/δ activation.


Asunto(s)
Humanos , Isoflavonas/farmacología , Receptores Activados del Proliferador del Peroxisoma/efectos de los fármacos , Semillas/química , Glycine max/química , Activación Transcripcional/efectos de los fármacos , Cromatografía Líquida de Alta Presión , Isoflavonas/aislamiento & purificación , Semillas/genética , Glycine max/genética
4.
SPJ-Saudi Pharmaceutical Journal. 2007; 15 (3-4): 190-195
en Inglés, Arabe | IMEMR | ID: emr-93566

RESUMEN

From the aerial parts of Crotalaria thebaica [Del] DC [Fabaceae] three segma pyrones [1-3] together with an isoflavone [tecreroginin] [4] were isolated. The structures of the isolated compounds were characterized by using different methods of spectral analysis including, IR, UV, NMR and MS.


Asunto(s)
Pironas/aislamiento & purificación , Componentes Aéreos de las Plantas , Isoflavonas/aislamiento & purificación , Fabaceae
5.
DARU-Journal of Faculty of Pharmacy Tehran University of Medical Sciences. 2004; 12 (2): 54-7
en Inglés | IMEMR | ID: emr-65639

RESUMEN

Two isoflavone, irilin A and irisone B were isolated from Iris songarica and their structures were determined by 1 and 2 D-NMR, IR, UV and MS. The effect of solvent on 1H-NMR spectra of irisone B have been studied


Asunto(s)
Plantas Medicinales , Isoflavonas/aislamiento & purificación
6.
Indian J Exp Biol ; 1998 Sep; 36(9): 907-10
Artículo en Inglés | IMSEAR | ID: sea-59202

RESUMEN

Garcinia kola, (a herb grown in Nigeria; calorific value 358.54 k.cal/100 g) inhibited in vitro lipid peroxidation of rat liver homogenate in a dose dependent manner. The inhibitory activity of G.kola was not affected by heating (100 degrees C/10 min). The antioxidant component of G.kola was soluble in aqueous and ethanolic media. The active component(s) in G. kola responsible for its inhibitory activity on lipid peroxidation is tentatively identified as isoflavones.


Asunto(s)
Animales , Antioxidantes/aislamiento & purificación , Isoflavonas/aislamiento & purificación , Peroxidación de Lípido/efectos de los fármacos , Hígado/efectos de los fármacos , Extractos Vegetales/aislamiento & purificación , Plantas Medicinales , Ratas , Ratas Wistar
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA